MedTrace Logo

PAFP Provider Feedback Trial in Nepal

NCT03071029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12000

Last updated 2017-05-09

No results posted yet for this study

Summary

A six-month RCT conducted within 36 health centres throughout urban and rural Nepal. The purpose of the RCT is to test the effectiveness of a peer comparison intervention at increasing uptake of long-acting reversible contraceptives (LARCs) as a percentage of PAFP uptake among clients who receive a safe abortion at a Marie Stopes International Nepal. The total sample size will be \~12,000 safe abortion clients. The primary outcome of interest is LARCs among safe abortion clients at Marie Stopes Centres in Nepal. The secondary outcome is to evaluate the impact of behaviorally designed intervention on the service providers' engagement in discussing measures to increase PAFP LARC uptake among women.

Conditions

  • Health Behavior

Interventions

BEHAVIORAL

Monthly PAFP rates displayed at clinics.

Providers will receive visual and text feedback on their centre's PAFP uptake rates as they compare to the uptake rates of other centres. The feedback will be delivered monthly in a physical paper format.

Sponsors & Collaborators

  • Ideas42

    collaborator INDUSTRY

  • Marie Stopes International

    lead OTHER

Principal Investigators

  • Saugato Datta · Ideas42

  • Karina Lorenzana · Ideas42

  • Pragya Gartoulla, PhD · Marie Stopes Nepal

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03071029 on ClinicalTrials.gov